| Date Filed | Type | Description |
| 05/12/2023 |
4
| LALANDE KEVIN M. (Director) has filed a Form 4 on LUMOS PHARMA, INC.|
Txns:
| Granted 3,345 options to buy
@ $3.42, valued at
$11.4k
|
|
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/18/2020 |
4
| LALANDE KEVIN M. (10% Owner) has filed a Form 4 on Molecular Templates, Inc.|
Txns:
| Sold 500,000 shares
@ $13.05, valued at
$6.5M
|
|
| 06/01/2020 |
4
| LALANDE KEVIN M. (10% Owner) has filed a Form 4 on Molecular Templates, Inc.|
Txns:
| Granted 15,000 options to buy
@ $15.43, valued at
$231.5k
|
|
| 05/22/2020 |
4
| LALANDE KEVIN M. (10% Owner) has filed a Form 4 on Molecular Templates, Inc.|
Txns:
| Sold 300,000 shares
@ $16.51, valued at
$5M
|
|
| 05/04/2020 |
4
| LALANDE KEVIN M. (10% Owner) has filed a Form 4 on Molecular Templates, Inc.|
Txns:
| Disposed of 1,000,000 shares
@ $0 |
|
| 04/07/2020 |
4
| LALANDE KEVIN M. (Director) has filed a Form 4 on LUMOS PHARMA, INC.|
Txns:
| Granted 709 shares
@ $0
Granted 5,684 options to buy
@ $7.78, valued at
$44.2k
|
|
| 03/30/2020 |
3
| LALANDE KEVIN M. (Director) has filed a Form 3 on LUMOS PHARMA, INC. |
| 05/30/2019 |
4
| LALANDE KEVIN M. (10% Owner) has filed a Form 4 on Molecular Templates, Inc.|
Txns:
| Granted 15,000 options to buy
@ $8.21, valued at
$123.2k
|
|
| 06/04/2018 |
4
| LALANDE KEVIN M. (10% Owner) has filed a Form 4 on Molecular Templates, Inc.|
Txns:
| Granted 15,000 options to buy
@ $6.31, valued at
$94.7k
|
|
| 10/11/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/11/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/13/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/08/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/09/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/28/2016 |
4
| LALANDE KEVIN M. (Director) has filed a Form 4 on LDR HOLDING CORP|
Txns:
| Granted 6,000 restricted stock units
@ $0 |
|
| 02/18/2016 |
4
| LALANDE KEVIN M. (Director) has filed a Form 4 on LDR HOLDING CORP|
Txns:
| Exercised 3,000 restricted stock units
@ $0 |
|
| 10/08/2013 |
3
| LALANDE KEVIN M. (Director) has filed a Form 3 on LDR HOLDING CORP |